342 related articles for article (PubMed ID: 18768419)
1. Industry support of medical education.
Relman AS
JAMA; 2008 Sep; 300(9):1071-3. PubMed ID: 18768419
[No Abstract] [Full Text] [Related]
2. Pharmaceutical industry support for continuing medical education programs: a review of current ethical guidelines.
Rosner F
Mt Sinai J Med; 1995 Nov; 62(6):427-30. PubMed ID: 8692156
[TBL] [Abstract][Full Text] [Related]
3. New developments in managing physician-industry relationships.
Rothman DJ; Chimonas S
JAMA; 2008 Sep; 300(9):1067-9. PubMed ID: 18768417
[No Abstract] [Full Text] [Related]
4. Pharma PR or medical education?
Rentmeester CA
Hastings Cent Rep; 2005; 35(2):6. PubMed ID: 15957306
[No Abstract] [Full Text] [Related]
5. Pharma PR or medical education?
Roselin JM
Hastings Cent Rep; 2005; 35(2):5-6. PubMed ID: 15957305
[No Abstract] [Full Text] [Related]
6. Generation next: a hope for ethics? In era of conflicts of interest, signs of progress center on impressionable youth.
Sloane T
Mod Healthc; 2008 May; 38(18):23. PubMed ID: 18557480
[No Abstract] [Full Text] [Related]
7. Fighting graft--it's academic. Medical centers must embrace conflict rules: critics.
Romano M
Mod Healthc; 2006 Jan; 36(5):8-10. PubMed ID: 16479773
[No Abstract] [Full Text] [Related]
8. Pharma PR or medical education?
Sweeney HA
Hastings Cent Rep; 2005; 35(2):4; author reply 5. PubMed ID: 15957304
[No Abstract] [Full Text] [Related]
9. Rethinking continuing medical education.
Pisacane A
BMJ; 2008 Aug; 337():a973. PubMed ID: 18703654
[No Abstract] [Full Text] [Related]
10. Managed care and medical education.
Kuttner R
N Engl J Med; 1999 Sep; 341(14):1092-6. PubMed ID: 10502601
[No Abstract] [Full Text] [Related]
11. Academic medical centers and conflicts of interest.
Watson PY; Musial JL; Khandewal AK; Buckley JD
JAMA; 2006 Jun; 295(24):2847-8; author reply 2848-9. PubMed ID: 16804147
[No Abstract] [Full Text] [Related]
12. Rebuttal: Is CME a drug-promotion tool?: NO.
Marlow B
Can Fam Physician; 2007 Nov; 53(11):1877, 1878-9. PubMed ID: 18000248
[No Abstract] [Full Text] [Related]
13. Ethics for the pediatrician: physician interaction with the pharmaceutical industry.
Cicero MX; Curi MB; Mercurio M
Pediatr Rev; 2011 Jan; 32(1):e1-3. PubMed ID: 21196498
[No Abstract] [Full Text] [Related]
14. Rebuttal: Is CME a drug-promotion tool?: YES.
Steinman MA; Baron RB
Can Fam Physician; 2007 Nov; 53(11):1877, 1878-9. PubMed ID: 18000249
[No Abstract] [Full Text] [Related]
15. Health industry practices that create conflicts of interest: a policy proposal for academic medical centers.
Brennan TA; Rothman DJ; Blank L; Blumenthal D; Chimonas SC; Cohen JJ; Goldman J; Kassirer JP; Kimball H; Naughton J; Smelser N
JAMA; 2006 Jan; 295(4):429-33. PubMed ID: 16434633
[TBL] [Abstract][Full Text] [Related]
16. The ethics of industry support for professional education in medicine.
Mamdani B
Indian J Med Ethics; 2008; 5(4):177-80. PubMed ID: 18988379
[No Abstract] [Full Text] [Related]
17. Industry support and professional medical associations.
Kahn N
JAMA; 2009 Aug; 302(7):737; author reply 739. PubMed ID: 19690302
[No Abstract] [Full Text] [Related]
18. Institutional academic industry relationships.
Campbell EG; Weissman JS; Ehringhaus S; Rao SR; Moy B; Feibelmann S; Goold SD
JAMA; 2007 Oct; 298(15):1779-86. PubMed ID: 17940234
[TBL] [Abstract][Full Text] [Related]
19. Rx: professional integrity (prn).
Engelman K
J Clin Hypertens (Greenwich); 2006 Mar; 8(3):232. PubMed ID: 16578956
[No Abstract] [Full Text] [Related]
20. PERMA: a model for institutional leadership and culture change.
Slavin SJ; Schindler D; Chibnall JT; Fendell G; Shoss M
Acad Med; 2012 Nov; 87(11):1481. PubMed ID: 23111270
[No Abstract] [Full Text] [Related]
[Next] [New Search]
